Group One Trading
BNTX icon

Group One Trading’s BioNTech BNTX Stock Holding History

Group One Trading’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32M Buy
360,200
+334,100
+1,280% +$34.3M 0.06% 312
2025
Q4 		$2.48M Sell
26,100
-22,900
-47% -$2.31M ﹤0.01% 2082
2025
Q3 		$4.83M Sell
49,000
-18,700
-28% -$2M 0.01% 1506
2025
Q2 		$7.21M Buy
67,700
+23,400
+53% +$2.36M 0.02% 1044
2025
Q1 		$4.03M Sell
44,300
-40,600
-48% -$4.55M 0.01% 1241
2024
Q4 		$9.67M Sell
84,900
-26,300
-24% -$3M 0.02% 720
2024
Q3 		$13.2M Buy
111,200
+54,100
+95% +$4.97M 0.04% 461
2024
Q2 		$4.59M Buy
57,100
+1,500
+3% +$137K 0.02% 853
2024
Q1 		$5.13M Sell
55,600
-30,200
-35% -$2.9M 0.02% 812
2023
Q4 		$9.06M Buy
85,800
+40,900
+91% +$4.12M 0.02% 753
2023
Q3 		$4.88M Sell
44,900
-6,100
-12% -$675K 0.02% 958
2023
Q2 		$5.5M Buy
51,000
+8,100
+19% +$911K 0.02% 883
2023
Q1 		$5.34M Sell
42,900
-145,600
-77% -$20M 0.02% 808
2022
Q4 		$28.3M Buy
188,500
+54,400
+41% +$8.37M 0.07% 294
2022
Q3 		$18.1M Sell
134,100
-77,000
-36% -$11.8M 0.04% 440
2022
Q2 		$31.5M Sell
211,100
-102,300
-33% -$15.6M 0.05% 315
2022
Q1 		$53.5M Sell
313,400
-207,100
-40% -$34.8M 0.05% 241
2021
Q4 		$134M Buy
520,500
+95,200
+22% +$26.1M 0.11% 105
2021
Q3 		$116M Buy
425,300
+138,700
+48% +$44.1M 0.13% 104
2021
Q2 		$64.2M Buy
286,600
+61,200
+27% +$11.5M 0.08% 198
2021
Q1 		$24.6M Buy
225,400
+140,200
+165% +$14.9M 0.04% 440
2020
Q4 		$6.95M Sell
85,200
-8,600
-9% -$844K 0.01% 1055
2020
Q3 		$6.49M Buy
93,800
+76,300
+436% +$5.47M 0.02% 750
2020
Q2 		$1.17M Buy
+17,500
New +$874K 0.01% 1888

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's BNTX Position: Q1 2026 in Review

Group One Trading increased its BioNTech (BNTX) stake by 4,185% in Q1 2026, buying an estimated $10.4M and bringing the position to 103,948 shares worth $9.24M. The position accounts for 0.02% of the portfolio, ranked #890.

Group One Trading first reported a position in BNTX in Q2 2020 and has held it in 24 quarters since. The position peaked at $38.1M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Group One Trading held 103,948 shares of BioNTech worth $9.24M as of Q1 2026.
  • Group One Trading bought 101,522 BioNTech shares in Q1 2026, an estimated $10.4M.
  • BioNTech made up 0.02% of Group One Trading's portfolio in Q1 2026, its #890 holding.
  • Group One Trading first reported a position in BioNTech in Q2 2020 and has held it in 24 quarters since.
  • Group One Trading's BioNTech position peaked at $38.1M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.